Brief: Cullinan Therapeutics Q3 Operating Expenses USD 55.595 Million
Nov 06 (Reuters) - Cullinan Therapeutics Q3 operating income USD -55.595 million vs. IBES estimate USD -63.3 million. Q3 net income USD -50.61 million Q3 cash & investments USD 475.5 million